献血者抗-TP筛查反应性确认与复查研究

余琴 ,  许婷婷 ,  陈邦锐 ,  赵磊

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 928 -933.

PDF (2201KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (7) : 928 -933. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.07.017
论著

献血者抗-TP筛查反应性确认与复查研究

作者信息 +

Confirmation and re-examination of reactive anti-TP screening in blood donors

Author information +
文章历史 +
PDF (2253K)

摘要

目的 对抗-TP ELISA 筛查反应性献血者标本进行确认,分析抗-TP ELISA 反应性献血者复查实施情况,为有效制定复查检测策略提供数据支撑。方法 采用梅毒螺旋体明胶颗粒凝集试验(TPPA) 检测 331 份抗-TP ELISA 筛查反应性(双试剂反应性 224 份、单试剂反应性 107 份) 标本。 对既往抗-TP ELISA 单试剂反应性并于2020-2024 年主动申请复查的献血者采集血样标本共 136 份,按照《血站技术操作规程(2019 版)》进行传染病指标的检测,其中抗-TP 筛查使用 2 个不同厂家的 ELISA 试剂,HBV/ HCV/ HIV 核酸检测采用单人份模式。 如果抗-TP检测结果呈单试剂反应性则补充 WB 或 TPPA 确证试验。 采用 χ2 检验或 Fisher 精确检验来评估不同试剂组合抗-TP 确证阳性率的差异。结果 331 份标本中双试剂反应性标本确证阳性率为93. 8%(210/ 224),单试剂反应性标本确证阳性率为 2. 8% (3/ 107)。 不同试剂组合双试剂反应性标本确证阳性率分别为 91. 7% (95% CI:85. 6% -95. 5%),95. 6%(95% CI:85. 2%-98. 8%),96. 6%(95% CI:86. 2%-97. 3%)(均为 P>0. 05)。 2020-2024 年抗-TP ELISA 单试剂反应性献血者 994 人,主动申请复查 136 人(136/ 994,13. 68%)。 经第 1 轮复查检测,88 人复查合格(88/ 136,64. 71%),18 人被永久屏蔽(18/ 136,13. 24%)。 被永久屏蔽的献血者,12 人仍然呈现出抗-TP ELISA 单试剂反应性,其中 8 人确证为 TP 特异性抗体阳性,4 人为不确定性结果;另外 6 人转变为双试剂反应性。结论 抗-TP ELISA 双试剂反应性具有较高的真阳性率,相应的献血者可以直接屏蔽;绝大多数抗-TP ELISA 单试剂反应性为假阳性,及时开展确证或补充检测可尽快告知献血者评估结果、减少后续不必要的复查,有助于提升献血者服务质量和管理效率,防止献血者流失。

Abstract

Objective To confirm the reactive anti-TP ELISA screening results in blood donor samples,and analyze implementation of re-examination among reactive donors, so as to provide data support for effectively formulating re-examination strategies. Methods Confirmation tests were performed on 331 samples (including 224 cases with dual-reagent reactivity and 107 cases with single-reagent reactivity) using treponema pallidum particle agglutination assays (TPPA). A total of 136 blood samples were collected from blood donors who have previously tested for anti-TP ELISA with single-reagent reactivity and voluntarily applied for re-examination from 2020 to 2024. Infectious disease indicators were detected in accordance with the " Technical Operating Procedures of Blood Stations(2019 Edition)" . Among them, anti-TP screening was performed using ELISA reagents from two different manufacturers, and HBV/ HCV/ HIV nucleic acid testing was conducted using an individual donation nucleic acid testing (ID-NAT) mode. Supplementary tests (WB or TPPA) were conducted on samples with anti-TP ELISA single-reagent reactivity. A two-sided Pearson′s chi-squared test or Fisher′s exact test was used to evaluate the differences of the positive rates of anti-TP among different groups or reagents. Results Among the 331 samples,the confirmed positive rate was 93. 75% (210/ 224) for dual-reagent reactive samples, and 2. 8% (3/ 107) for single-reagent reactive samples. The confirmed positive rates of double reagent reactive samples with different reagent combinations were 91. 7%(95% CI: 85. 6%-95. 5%),95. 6%(95% CI: 85. 2%-98. 8%), 96. 6%(95% CI: 86. 2%-97. 3%) respectively, with no statistically significant difference (χ2 = 1. 597,P= 0. 463). From 2020 to 2024, 994 donors showed anti-TP ELISA single-reagent reactive results. Among them, 136(136/ 994, 13. 68%) donors voluntarily applied for re-examination. After the first round of re-examination, 88 (88/ 136, 64. 71%)donors passed the re-examination, and 18 donors were permanently deffered (18/ 136, 13. 24%). Among the permanently quarantined donors, 12 donors remained anti-TP ELISA single-reagent reactive, including 8 confirmed positive for TP-specific antobodies and 4 with indeterminate results. The remaining 6 donors converted to dual-reagent reactive. Conclusion The dual-reagent reactive results in anti-TP ELISA has a high true positive rate, and the corresponding blood donors can be directly deffered. The majority of single-reagent reactive anti TP-ELISA results are false positives. Timely confirmation or supplementary testing allows prompt notification of evaluation results to blood donors, and reduces unnecessary follow-up examinations. This helps improve the quality of blood donor services and management efficiency, as well as prevent blood donor attrition.

关键词

献血者 / 梅毒螺旋体 / 酶联免疫吸附实验 / 免疫印迹法 / 梅毒螺旋体明胶凝集实验 / 献血者复查

Key words

blood donor / treponema pallidum(TP) / enzyme-linked immunosorbnent assay (ELISA) / Western blotting / treponema pallidum particle agglutination (TPPA) / donor re-examination

引用本文

引用格式 ▾
余琴,许婷婷,陈邦锐,赵磊. 献血者抗-TP筛查反应性确认与复查研究[J]. 中国输血杂志, 2026, 39(7): 928-933 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.017

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

张伟芳,陈永超,吴蓉. 珠海市无偿献血者梅毒 ELISA不合格结果与 TPPA 确证实验的对比分析[J].中国社区医师,2021,37(24):115-116.

[2]

ZHANG W F, CHEN Y C, WU R. Syphilis confirmatory testing and syphilis infection status analysis of the blood donors on the unqualified results of anti-TP antibody screening[J]. Chin Community Doctors, 2021, 37(24):115-116.

[3]

曾雪珍,赵俊鹏,陈云龙,等. 2019 年深圳地区无偿献血者梅毒筛查结果分析[J].中国输血杂志,2020,33(10):1083-1086.

[4]

ZENG X Z, ZHAO J P, CHEN Y L, et al. Analysis of TP screening results among voluntary blood donors in 2019, Shenzhen[J].Chin J Blood Transfusion, 2020, 33(10):1083-1086.

[5]

王鹏坤,褚德旭,范恩勇,等. 113 例献血者梅毒抗体 ELISA 法阳性与 TPPA 确证结果比对分析[J].临床血液学杂志,2017,30(6):436-440.

[6]

WANG P K, CHU D X, FAN E Y, et al. Comparative analysis of TPPA confirmation results of 113 blood donors with positive syphilis antibody tested by ELISA[J].J Clinical Hematology, 2017,30(6):436-440.

[7]

魏旖辉,王艺芳,陈明军,等. 无偿献血者梅毒 ELISA不合格结果与 TPPA 确证试验的对比分析[J].临床血液学杂志,2025,38(2):122-130.

[8]

WEI Y H, WANG Y F, CHEN M J, et al. Comparative analysis of unqualified results of syphilis ELISA test and TPPA confirmation test among voluntary blood donors[J].J Clinical Hematology, 2025,38(2):122-130.

[9]

王桂喜,刘丽,高尚峰. ELISA 方法检测梅毒抗体灰区设置的探讨[J].中国输血杂志,2019,32 (3):254-256.

[10]

WANG G X, LIU L, GAO S F. Gray zone parameter analysis of anti-TP detection by enzyme-linked immunosorbent assay[J].Chin J Blood Transfusion, 2019,32(3):254-256.

[11]

黄力勤,常乐,邬林枫,等. 血液筛查 ELISA 灰区设定的血站支出成本与效果的卫生经济学评估[J].中国输血杂志,2022,35(7):764-768.

[12]

WANG L Q, CHANG L, WU L F, et al. Health economics evaluation of the cost and effectiveness of gray zone setting in blood ELISA screening[J].Chin J Blood Transfusion, 2022,35(7):764-768.

[13]

黄伯泉,李仲平,梁浩坚,等. 献血人群抗-TP ELISA 检测呈反应性 S/ CO 值 ROC 曲线分析[J].广东医科大学学报,2021,39(2):215-219.

[14]

HUANG B Q, LI Z P, LIANG H J, et al. ROC curve analysis of reactive S/ CO value in blood donors with anti-TP ELISA[J].J Guangdong Medical University, 2021, 39(2):215-219.

[15]

何芮,李玲,钱立琼,等. 梅毒螺旋体筛查反应性献血者 S/ CO 值与真阳性的相关性研究[J].中国输血杂志,2019,32(8):761-764.

[16]

HE R, LI L, QIAN L Q, et al. Research about the correlation between S/ CO value and true positivity of reactive blood donors in anti-TP screening[J].Chin J Blood Transfusion, 2019, 32(8):761-764.

[17]

胡京辉,葛红卫,王瑞,等. 献血者 TP 抗体 ELISA 检测屏蔽界限的探讨[J].中国实验血液学杂志,2020,28(3):956-960.

[18]

HU J H, GE H W, WANG R, et al. Establishing the blood donor deferral criterion in TP ELISA test[J].J Experimental Hematology, 2020, 28(3):956-960.

[19]

高楠,黄力勤,王瑞,等. 2 种梅毒螺旋体抗体酶联免疫吸附试剂性能评价[J].中国实验血液学杂志,2018,26(3) :905-910.

[20]

GAO N, HUANG L Q, WANG R, et al. Evaluation of the performance of two kinds of anti-TP enzyme linked immunosorbent assay[J].J Experimental Hematology, 2018, 26(3):905-910.

[21]

秦龑丽,冯惟萍,戴田,等. 梅毒抗体反应性献血者筛查方案和复查策略研究[J].中国卫生检验杂志,2018,28(9):1076-1078.

[22]

QIN Y L, FENG W P, DAI T, et al. Study on screening program and re-examination strategy of syphilis antibody donors[J].Chin J Health Lab Tec, 2018,28(9):1076-1078.

[23]

邹姣丽,陈庆恺,袁秋婷,等. 无偿献血者梅毒螺旋体抗体反应性确证结果研究[J].中国输血杂志,2024,377(7):790-796.

[24]

ZOU J L, CHEN Q K, YUAN Q T, et al. Study on the confirmation of treponema pallidum antibody reactivity in blood donors[J].Chin J Blood Transfusion, 2024,377(7):790-796.

[25]

王东,臧亮,陈辉,等. 梅毒螺旋体抗体单试剂反应性献血者复查策略研究[J].中国输血杂志,2018,31(10):1177-1180.

[26]

WANG D, ZANG L, CHEN H, et al. Re-examination strategy for single-reactive blood donors in anti-TP ELISA tests[J].Chin J Blood Transfusion, 2018, 31 (10):1177-1180.

AI Summary AI Mindmap
PDF (2201KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉